# Transfer of Subjects From Subutex/Suboxone to RBP-6300

> **NCT01582347** · PHASE2 · COMPLETED · sponsor: **Indivior Inc.** · enrollment: 143 (actual)

## Conditions studied

- Opioid Related Disorder

## Interventions

- **DRUG:** RBP-6300
- **DRUG:** Subutex®/Suboxone®
- **DRUG:** Placebo for RBP-6300
- **DRUG:** Placebo for Subutex®/Suboxone®

## Key facts

- **NCT ID:** NCT01582347
- **Lead sponsor:** Indivior Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2012-11
- **Final completion:** 2012-11
- **Target enrollment:** 143 (ACTUAL)
- **Last updated:** 2017-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01582347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01582347, "Transfer of Subjects From Subutex/Suboxone to RBP-6300". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01582347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*